...
atnf-img

180 Life Sciences Corp, Common Stock

ATNF

NAQ

$2.9

+$1.03

(55.08%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$3.70M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0.2343
Volume info-icon
This is the total number of shares traded during the most recent trading day.
0
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.25
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.16 L
$8 H
$2.9

About 180 Life Sciences Corp, Common Stock

180 Life Sciences Corp., a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. The company product development platforms includes fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which has completed phase 2a and phase 2b proof-of-concept clinical trials for early-stage Dupuytren's Contracture; Synthetic Cannabidiol (CBD) Analogs platform, which are synthetic pharmaceutical grade molecules close or distant analogs of non-psychoactive cannabinoids, such as CBD for the treatment of inflammatory diseases and pain; and a7nAChR platform, an immune suppressive, that focuses on alpha 7 nicotinic acetylcholine receptor. The company is headquartered in Palo Alto, California. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameATNFSectorS&P500
1-Week Return2.75%-0.33%-1.49%
1-Month Return-15.77%-4.57%-0.37%
3-Month Return--9.96%3.89%
6-Month Return25.5%-5.67%9.34%
1-Year Return-47.93%2.53%25.19%
3-Year Return-99.88%-1.43%24.7%
5-Year Return-99.95%34.73%85.39%
10-Year Return-99.95%102.14%187.19%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue72.24K-116.30K109.00K105.67K[{"date":"2019-12-31","value":62.12,"profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":93.73,"profit":true},{"date":"2023-12-31","value":90.87,"profit":true}]
Gross Profit(72.24K)-(116.30K)(109.00K)(105.67K)[{"date":"2019-12-31","value":-7224400,"profit":false},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-11629700,"profit":false},{"date":"2022-12-31","value":-10900400,"profit":false},{"date":"2023-12-31","value":-10567500,"profit":false}]
Gross Margin-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Operating Expenses25.22M5.65M5.65M39.64M13.48M[{"date":"2019-12-31","value":63.62,"profit":true},{"date":"2020-12-31","value":14.25,"profit":true},{"date":"2021-12-31","value":14.25,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":34,"profit":true}]
Operating Income(20.86M)(5.65M)(5.65M)(17.90M)(13.48M)[{"date":"2019-12-31","value":-2086328600,"profit":false},{"date":"2020-12-31","value":-564811200,"profit":false},{"date":"2021-12-31","value":-564811200,"profit":false},{"date":"2022-12-31","value":-1789796500,"profit":false},{"date":"2023-12-31","value":-1347750000,"profit":false}]
Total Non-Operating Income/Expense(4.72M)(5.26M)(5.44M)(21.80M)(8.85M)[{"date":"2019-12-31","value":-472166900,"profit":false},{"date":"2020-12-31","value":-525637300,"profit":false},{"date":"2021-12-31","value":-544258100,"profit":false},{"date":"2022-12-31","value":-2179771000,"profit":false},{"date":"2023-12-31","value":-884786700,"profit":false}]
Pre-Tax Income(25.40M)(10.90M)(10.90M)(39.67M)(22.28M)[{"date":"2019-12-31","value":-2540354200,"profit":false},{"date":"2020-12-31","value":-1090448500,"profit":false},{"date":"2021-12-31","value":-1090448500,"profit":false},{"date":"2022-12-31","value":-3966900800,"profit":false},{"date":"2023-12-31","value":-2228452600,"profit":false}]
Income Taxes9.50K(20.43K)(20.43K)942.75K(2.35M)[{"date":"2019-12-31","value":1.01,"profit":true},{"date":"2020-12-31","value":-2.17,"profit":false},{"date":"2021-12-31","value":-2.17,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-249.21,"profit":false}]
Income After Taxes(25.41M)(10.88M)(10.88M)(40.61M)(19.94M)[{"date":"2019-12-31","value":-2541303800,"profit":false},{"date":"2020-12-31","value":-1088405800,"profit":false},{"date":"2021-12-31","value":-1088405800,"profit":false},{"date":"2022-12-31","value":-4061175700,"profit":false},{"date":"2023-12-31","value":-1993511200,"profit":false}]
Income From Continuous Operations(25.39M)(10.88M)(20.32M)(38.73M)(40.45M)[{"date":"2019-12-31","value":-2539404600,"profit":false},{"date":"2020-12-31","value":-1088405800,"profit":false},{"date":"2021-12-31","value":-2032464800,"profit":false},{"date":"2022-12-31","value":-3872625900,"profit":false},{"date":"2023-12-31","value":-4045028500,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(25.39M)(10.88M)(10.88M)(38.73M)(19.94M)[{"date":"2019-12-31","value":-2539404600,"profit":false},{"date":"2020-12-31","value":-1088405800,"profit":false},{"date":"2021-12-31","value":-1088405800,"profit":false},{"date":"2022-12-31","value":-3872625900,"profit":false},{"date":"2023-12-31","value":-1993511200,"profit":false}]
EPS (Diluted)(0.16)(1.53)(2.12)(9.49)(29.87)[{"date":"2019-12-31","value":-16.4,"profit":false},{"date":"2020-12-31","value":-152.95,"profit":false},{"date":"2021-12-31","value":-212,"profit":false},{"date":"2022-12-31","value":-949.07,"profit":false},{"date":"2023-12-31","value":-2986.54,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

ATNF
Cash Ratio 0.03
Current Ratio 0.19

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

ATNF
ROA (LTM) -63.50%
ROE (LTM) -398.58%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

ATNF
Debt Ratio Lower is generally better. Negative is bad. 0.64
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.36

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

ATNF
Trailing PE 0.23
Forward PE 6.08
P/S (TTM) 0.00
P/B 0.99
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is 180 Life Sciences Corp share price today?

180 Life Sciences Corp (ATNF) share price today is $2.9

Can Indians buy 180 Life Sciences Corp shares?

Yes, Indians can buy shares of 180 Life Sciences Corp (ATNF) on Vested. To buy 180 Life Sciences Corp from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ATNF stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of 180 Life Sciences Corp be purchased?

Yes, you can purchase fractional shares of 180 Life Sciences Corp (ATNF) via the Vested app. You can start investing in 180 Life Sciences Corp (ATNF) with a minimum investment of $1.

How to invest in 180 Life Sciences Corp shares from India?

You can invest in shares of 180 Life Sciences Corp (ATNF) via Vested in three simple steps:

  • Click on Sign Up or Invest in ATNF stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in 180 Life Sciences Corp shares
What is 180 Life Sciences Corp 52-week high and low stock price?

The 52-week high price of 180 Life Sciences Corp (ATNF) is $8. The 52-week low price of 180 Life Sciences Corp (ATNF) is $1.16.

What is 180 Life Sciences Corp price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of 180 Life Sciences Corp (ATNF) is 0.2343

What is 180 Life Sciences Corp price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of 180 Life Sciences Corp (ATNF) is 0.99

What is 180 Life Sciences Corp dividend yield?

The dividend yield of 180 Life Sciences Corp (ATNF) is 0.00%

What is the Market Cap of 180 Life Sciences Corp?

The market capitalization of 180 Life Sciences Corp (ATNF) is $3.70M

What is 180 Life Sciences Corp’s stock symbol?

The stock symbol (or ticker) of 180 Life Sciences Corp is ATNF

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top